Loading stock data…
AFLAC Incorporated (AFL)
$117.21-1.15 (-0.97%)
Pre-Market$116.25-0.96 (-0.82%)· Last close Sep 4
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aflac Incorporated in the Financial Services sector is trading at $117.21 with a market capitalization of $58.8B. Wall Street consensus targets $118.53 (15 analysts), implying a +1.1% move over the next 12 months. The stock is currently 10% below its 52-week high of $130.22, remaining 3.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.41B↓ | $4.89B↑ | $4.79B↑ | $4.22B↑ | $3.45B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.28B↓ | $1.63B↓ | $2.05B↑ | $874.00M↑ | $195.00M |
| Net Income | $1.02B↓ | $1.38B↓ | $1.64B↑ | $599.00M↑ | $29.00M |
Peer Comparison
JPMBACGS
Fundamentals
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insuran...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$58.76B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.77
Beta
Defensive asset. Lower volatility than the S&P 500.
0.58
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.06%
ROE
Elite ROE. Management converts capital into profit efficiently.
16.04%
Volume
Today's trading volume
1.86M
Recent News
3 of Wall Street’s Safest High-Yield Dividend Stocks With Over 25-Year Increase Streaks
Not all Dividend Aristocrats are created equal, and three companies spanning payroll processing, supplemental insurance, and integrated energy have quietly stacked 25-plus years of annual raises through completely different cash engines.
AF Legal Group Ltd (ASX:AFL) (FY 2026) Earnings Call Highlights: Record Revenue and Strategic ...
AF Legal Group Ltd (ASX:AFL) reports a 29% surge in revenue to $35.5 million, with strong early FY27 momentum and a focus on cash generation.
5 Dividend Aristocrats That Belong in Every Income Portfolio
Not every Dividend Aristocrat deserves space in your portfolio right now, and with tariffs, rate pressure, and AI capex reshaping entire industries, picking the wrong ones could cost you real income. These five names survived a brutal four-factor ranking, but only one scored clean across the board.
Aflac (AFL) Stock Looks Cheap On Fair Value But Rich On Earnings
Aflac stock has delivered strong long term gains over the past five years, yet the current valuation signals are split between what the market is paying and what an intrinsic value estimate suggests the shares may be worth. The Excess Returns model points to a discount to intrinsic value, while earnings based multiples indicate the stock is priced more richly. A roughly 129.5% total return over five years highlights how Aflac has already rewarded patient shareholders, which raises the bar...
Globe Life's Health Insurance Growth Powers Earnings Momentum
GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.